{"transactions":[{"id":912219,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67058,"kind":"organization","name":"Vensana Capital I GP, LLC","position":1,"cik":"0001854073","reported_name":"Vensana Capital I GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67059,"kind":"organization","name":"Vensana Capital I, L.P.","position":2,"cik":"0001757539","reported_name":"Vensana Capital I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41682,"kind":"person","name":"Nielsen Kirk G.","position":3,"cik":"0001523522","reported_name":"Nielsen Kirk G.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67060,"kind":"person","name":"Klein Peter Justin","position":4,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series D Preferred Stock","published_at":"2026-02-10T18:08:58.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":2059573,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Vensana Capital I, L.P. (\"Vensana I\"). Vensana Capital I GP, LLC (\"Vensana GP I\") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the \"GP I Managing Directors\") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":359255},"source":{"system":"sec-edgar","filing":"0001193125-26-045028","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1854073/000119312526045028/ownership.xml","form_type":"4"}},{"id":912218,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67058,"kind":"organization","name":"Vensana Capital I GP, LLC","position":1,"cik":"0001854073","reported_name":"Vensana Capital I GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67059,"kind":"organization","name":"Vensana Capital I, L.P.","position":2,"cik":"0001757539","reported_name":"Vensana Capital I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41682,"kind":"person","name":"Nielsen Kirk G.","position":3,"cik":"0001523522","reported_name":"Nielsen Kirk G.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67060,"kind":"person","name":"Klein Peter Justin","position":4,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-2 Preferred Stock","published_at":"2026-02-10T18:08:58.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":3142015,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Vensana Capital I, L.P. (\"Vensana I\"). Vensana Capital I GP, LLC (\"Vensana GP I\") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the \"GP I Managing Directors\") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":548067},"source":{"system":"sec-edgar","filing":"0001193125-26-045028","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1854073/000119312526045028/ownership.xml","form_type":"4"}},{"id":912217,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67058,"kind":"organization","name":"Vensana Capital I GP, LLC","position":1,"cik":"0001854073","reported_name":"Vensana Capital I GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67059,"kind":"organization","name":"Vensana Capital I, L.P.","position":2,"cik":"0001757539","reported_name":"Vensana Capital I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41682,"kind":"person","name":"Nielsen Kirk G.","position":3,"cik":"0001523522","reported_name":"Nielsen Kirk G.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67060,"kind":"person","name":"Klein Peter Justin","position":4,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series C-1 Preferred Stock","published_at":"2026-02-10T18:08:58.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":3142015,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Vensana Capital I, L.P. (\"Vensana I\"). Vensana Capital I GP, LLC (\"Vensana GP I\") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the \"GP I Managing Directors\") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":548067},"source":{"system":"sec-edgar","filing":"0001193125-26-045028","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1854073/000119312526045028/ownership.xml","form_type":"4"}},{"id":912216,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67058,"kind":"organization","name":"Vensana Capital I GP, LLC","position":1,"cik":"0001854073","reported_name":"Vensana Capital I GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67059,"kind":"organization","name":"Vensana Capital I, L.P.","position":2,"cik":"0001757539","reported_name":"Vensana Capital I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41682,"kind":"person","name":"Nielsen Kirk G.","position":3,"cik":"0001523522","reported_name":"Nielsen Kirk G.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67060,"kind":"person","name":"Klein Peter Justin","position":4,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Series B Preferred Stock","published_at":"2026-02-10T18:08:58.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":false,"shares":9689922,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Vensana Capital I, L.P. (\"Vensana I\"). Vensana Capital I GP, LLC (\"Vensana GP I\") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the \"GP I Managing Directors\") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":1690230},"source":{"system":"sec-edgar","filing":"0001193125-26-045028","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1854073/000119312526045028/ownership.xml","form_type":"4"}},{"id":912215,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67058,"kind":"organization","name":"Vensana Capital I GP, LLC","position":1,"cik":"0001854073","reported_name":"Vensana Capital I GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67059,"kind":"organization","name":"Vensana Capital I, L.P.","position":2,"cik":"0001757539","reported_name":"Vensana Capital I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41682,"kind":"person","name":"Nielsen Kirk G.","position":3,"cik":"0001523522","reported_name":"Nielsen Kirk G.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67060,"kind":"person","name":"Klein Peter Justin","position":4,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T18:08:58.000Z","date":"2026-02-09","kind":"purchase","planned":false,"acquired":true,"shares":165000,"price":16,"value":2640000.0,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Vensana Capital I, L.P. (\"Vensana I\"). Vensana Capital I GP, LLC (\"Vensana GP I\") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the \"GP I Managing Directors\") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":3310619,"source":{"system":"sec-edgar","filing":"0001193125-26-045028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1854073/000119312526045028/ownership.xml","form_type":"4"}},{"id":912214,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67058,"kind":"organization","name":"Vensana Capital I GP, LLC","position":1,"cik":"0001854073","reported_name":"Vensana Capital I GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67059,"kind":"organization","name":"Vensana Capital I, L.P.","position":2,"cik":"0001757539","reported_name":"Vensana Capital I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41682,"kind":"person","name":"Nielsen Kirk G.","position":3,"cik":"0001523522","reported_name":"Nielsen Kirk G.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67060,"kind":"person","name":"Klein Peter Justin","position":4,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T18:08:58.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":359255,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Vensana Capital I, L.P. (\"Vensana I\"). Vensana Capital I GP, LLC (\"Vensana GP I\") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the \"GP I Managing Directors\") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":3145619,"source":{"system":"sec-edgar","filing":"0001193125-26-045028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854073/000119312526045028/ownership.xml","form_type":"4"}},{"id":912213,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67058,"kind":"organization","name":"Vensana Capital I GP, LLC","position":1,"cik":"0001854073","reported_name":"Vensana Capital I GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67059,"kind":"organization","name":"Vensana Capital I, L.P.","position":2,"cik":"0001757539","reported_name":"Vensana Capital I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41682,"kind":"person","name":"Nielsen Kirk G.","position":3,"cik":"0001523522","reported_name":"Nielsen Kirk G.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67060,"kind":"person","name":"Klein Peter Justin","position":4,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T18:08:58.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":548067,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Vensana Capital I, L.P. (\"Vensana I\"). Vensana Capital I GP, LLC (\"Vensana GP I\") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the \"GP I Managing Directors\") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2786364,"source":{"system":"sec-edgar","filing":"0001193125-26-045028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1854073/000119312526045028/ownership.xml","form_type":"4"}},{"id":912212,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67058,"kind":"organization","name":"Vensana Capital I GP, LLC","position":1,"cik":"0001854073","reported_name":"Vensana Capital I GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67059,"kind":"organization","name":"Vensana Capital I, L.P.","position":2,"cik":"0001757539","reported_name":"Vensana Capital I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41682,"kind":"person","name":"Nielsen Kirk G.","position":3,"cik":"0001523522","reported_name":"Nielsen Kirk G.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67060,"kind":"person","name":"Klein Peter Justin","position":4,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T18:08:58.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":548067,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Vensana Capital I, L.P. (\"Vensana I\"). Vensana Capital I GP, LLC (\"Vensana GP I\") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the \"GP I Managing Directors\") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":2238297,"source":{"system":"sec-edgar","filing":"0001193125-26-045028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854073/000119312526045028/ownership.xml","form_type":"4"}},{"id":912211,"issuer":{"id":5034,"kind":"organization","name":"SpyGlass Pharma, Inc."},"owners":[{"id":67058,"kind":"organization","name":"Vensana Capital I GP, LLC","position":1,"cik":"0001854073","reported_name":"Vensana Capital I GP, LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67059,"kind":"organization","name":"Vensana Capital I, L.P.","position":2,"cik":"0001757539","reported_name":"Vensana Capital I, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":41682,"kind":"person","name":"Nielsen Kirk G.","position":3,"cik":"0001523522","reported_name":"Nielsen Kirk G.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":67060,"kind":"person","name":"Klein Peter Justin","position":4,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2026-02-10T18:08:58.000Z","date":"2026-02-09","kind":"exercise","planned":false,"acquired":true,"shares":1690230,"ownership":{"direct":false,"nature":"See footnote"},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each of the Series B Preferred Stock, Series C-1 Preferred Stock, Series C-2 Preferred Stock, and Series D Preferred Stock automatically converted into shares of Common Stock on a one-for-5.7329 basis without payment of further consideration immediately prior to the completion of the Issuer's initial public offering of Common Stock and had no expiration date."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"These shares are held directly by Vensana Capital I, L.P. (\"Vensana I\"). Vensana Capital I GP, LLC (\"Vensana GP I\") is the general partner of Vensana I. Kirk Nielsen, a member of the Issuer's board of directors, and Peter Justin Klein (the \"GP I Managing Directors\") are the managing directors of Vensana GP I. Each of Vensana GP I and the GP I Managing Directors, in their capacities with respect to Vensana GP I, may be deemed to have voting, investment and dispositive power with respect to the shares held by Vensana I. Each of Vensana GP I and the GP I Managing Directors disclaims beneficial ownership of these securities and this report shall not be deemed an admission that any one of Vensana GP I or the GP I Managing Directors is the beneficial owner of such securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein."}],"balance_after":1690230,"source":{"system":"sec-edgar","filing":"0001193125-26-045028","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854073/000119312526045028/ownership.xml","form_type":"4"}},{"id":2681305,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2021-06-04T18:07:58.000Z","date":"2021-06-03","kind":"grant","acquired":true,"shares":14000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2022 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":14000,"derivative":{"exercise_price":3.53,"expiration_date":"2031-06-03","underlying":"Common Stock","underlying_shares":14000},"source":{"system":"sec-edgar","filing":"0001169245-21-000062","document":"wf-form4_162284446588544.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924521000062/wf-form4_162284446588544.xml","form_type":"4"}},{"id":2756716,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-04-05T17:00:21.000Z","date":"2021-04-01","kind":"grant","acquired":true,"shares":2470,"price":2.58,"value":6372.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,372.60 divided by $2.58, the closing price of Issuer's common stock on the NYSE American on April 1, 2021."}],"balance_after":369186,"source":{"system":"sec-edgar","filing":"0001209191-21-025193","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919121025193/doc4.xml","form_type":"4"}},{"id":2914607,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2021-01-06T19:11:07.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":6853,"price":0.9302,"value":6374.6606,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,374.66 divided by $0.9302, the closing price of Issuer's common stock on the NYSE American on January 4, 2021."}],"balance_after":366716,"source":{"system":"sec-edgar","filing":"0001209191-21-002365","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919121002365/doc4.xml","form_type":"4"}},{"id":3012436,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-10-05T18:19:35.000Z","date":"2020-10-01","kind":"grant","acquired":true,"shares":16375,"price":0.3893,"value":6374.7875,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,374.79 divided by $0.3893, the closing price of Issuer's common stock on the NYSE American on October 1, 2020."}],"balance_after":359863,"source":{"system":"sec-edgar","filing":"0001209191-20-053861","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919120053861/doc4.xml","form_type":"4"}},{"id":3050686,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-20T16:44:51.000Z","date":"2020-07-20","kind":"grant","acquired":true,"shares":273077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") grant. The RSUs vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the reporting person's continuous service through such vesting date."},{"field":"shares","element":"transactionShares","label":"F2","text":"This Form 4 amendment is being filed to reflect the correct vesting terms of the RSU grant."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":343488,"source":{"system":"sec-edgar","filing":"0001209191-20-047745","document":"doc4a.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919120047745/doc4a.xml","form_type":"4/A","original_submission_date":"2020-07-22"}},{"id":3077515,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-22T17:14:11.000Z","date":"2020-07-20","kind":"grant","acquired":true,"shares":273077,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") grant. The RSUs vest in eight equal installments with the first installment vesting on July 21, 2020 and the remaining RSUs vesting in six month increments commencing on November 15, 2020, subject to the Reporting Person's continuous service with the Issuer as of the applicable vesting date."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one share of the Issuer's common stock."}],"balance_after":343488,"source":{"system":"sec-edgar","filing":"0001209191-20-043334","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919120043334/doc4.xml","form_type":"4"}},{"id":3090683,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-07-02T17:53:57.000Z","date":"2020-07-01","kind":"grant","acquired":true,"shares":16905,"price":0.3771,"value":6374.8755,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,374.88 divided by $0.3771, the closing price of Issuer's common stock on the NYSE American on July 1, 2020."}],"balance_after":70411,"source":{"system":"sec-edgar","filing":"0001209191-20-040586","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919120040586/doc4.xml","form_type":"4"}},{"id":3120779,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2020-06-05T19:00:36.000Z","date":"2020-06-03","kind":"grant","acquired":true,"shares":16000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the 2021 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":16000,"derivative":{"exercise_price":4.86,"expiration_date":"2030-06-03","underlying":"Common Stock","underlying_shares":16000},"source":{"system":"sec-edgar","filing":"0001169245-20-000067","document":"wf-form4_159139801904624.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000116924520000067/wf-form4_159139801904624.xml","form_type":"4"}},{"id":3182327,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-04-03T17:20:01.000Z","date":"2020-04-01","kind":"grant","acquired":true,"shares":11184,"price":0.57,"value":6374.88,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,374.88 divided by $0.57, the closing price of Issuer's common stock on the NYSE American on April 1, 2020."}],"balance_after":53506,"source":{"system":"sec-edgar","filing":"0001209191-20-023311","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919120023311/doc4.xml","form_type":"4"}},{"id":3317437,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-06T18:33:55.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":6959,"price":0.916,"value":6374.444,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,374.44 divided by $0.916, the closing price of Issuer's common stock on the NYSE American on December 31, 2019."}],"balance_after":42322,"source":{"system":"sec-edgar","filing":"0001209191-20-002111","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919120002111/doc4.xml","form_type":"4"}},{"id":3400371,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-10-02T17:10:35.000Z","date":"2019-10-01","kind":"grant","acquired":true,"shares":6758,"price":0.94,"value":6352.52,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,375.00 divided by $0.94, the closing price of Issuer's common stock on the NYSE American on October 1, 2019."}],"balance_after":35363,"source":{"system":"sec-edgar","filing":"0001209191-19-051830","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919119051830/doc4.xml","form_type":"4"}},{"id":3467278,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-07-03T16:34:00.000Z","date":"2019-07-01","kind":"grant","acquired":true,"shares":3286,"price":1.94,"value":6374.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly retainer fees. The number of shares of common stock is equal to $6,375.00 divided by $1.94, the closing price of Issuer's common stock on the NYSE American on July 1, 2019."}],"balance_after":28605,"source":{"system":"sec-edgar","filing":"0001209191-19-041137","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919119041137/doc4.xml","form_type":"4"}},{"id":3504316,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-03T17:26:27.000Z","date":"2019-05-30","kind":"grant","acquired":true,"shares":86930,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the NYSE American on the date of grant, May 30, 2019."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made as compensation for the reporting person's service on the Issuer's board of directors. Under the Issuer's non-employee director compensation policy, each non-employee director who continues to serve as a member of the Issuer's board of directors is eligible to receive an annual stock option grant following each annual meeting of the Issuer's stockholders with a Black Scholes option value of $106,500."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the option will vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders meeting, subject to the reporting person's continuous service (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through such vesting date."}],"balance_after":86930,"derivative":{"exercise_price":1.97,"expiration_date":"2029-05-29","underlying":"Common Stock","underlying_shares":86930},"source":{"system":"sec-edgar","filing":"0001209191-19-033985","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919119033985/doc4.xml","form_type":"4"}},{"id":3530247,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2019-05-13T16:39:39.000Z","date":"2019-05-09","kind":"grant","acquired":true,"shares":11000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest upon the earlier of the one year anniversary of the grant date or the date of the 2020 annual meeting, subject to the reporting person's continuous service through each such date"}],"balance_after":11000,"derivative":{"exercise_price":13.23,"expiration_date":"2029-05-09","underlying":"Common Stock","underlying_shares":11000},"source":{"system":"sec-edgar","filing":"0001209191-19-029358","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919119029358/doc4.xml","form_type":"4"}},{"id":3563658,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-04-03T16:54:41.000Z","date":"2019-04-01","kind":"grant","acquired":true,"shares":2895,"price":2.31,"value":6687.45,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This common stock was issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly\nretainer fees. The number of shares of common stock is equal to $6,687.45   divided by $2.31, the closing price of Issuer's common stock on the\nNYSE American on April 1, 2019."}],"balance_after":25319,"source":{"system":"sec-edgar","filing":"0001209191-19-023243","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919119023243/doc4.xml","form_type":"4"}},{"id":3623486,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-employee Director Stock Option (right to buy)","published_at":"2019-03-01T16:48:43.000Z","date":"2019-02-27","kind":"grant","acquired":true,"shares":36000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to the option shall vest in equal monthly installments over 36 months from October 17, 2018, subject to the reporting person's continued service through each such date."}],"balance_after":36000,"derivative":{"exercise_price":3.15,"expiration_date":"2029-02-27","underlying":"Common Stock","underlying_shares":36000},"source":{"system":"sec-edgar","filing":"0001209191-19-015036","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919119015036/doc4.xml","form_type":"4"}},{"id":3703081,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-01-04T16:33:37.000Z","date":"2019-01-02","kind":"grant","acquired":true,"shares":4507,"price":2.69,"value":12123.83,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This common stock was issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly\nretainer fees. The number of shares of common stock is equal to $12,125  divided by $2.69, the closing price of Issuer's common stock on the\nNYSE American on January 2, 2019."}],"balance_after":22424,"source":{"system":"sec-edgar","filing":"0001209191-19-001989","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919119001989/doc4.xml","form_type":"4"}},{"id":3784208,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-10-24T17:01:47.000Z","date":"2018-10-22","kind":"exercise","acquired":false,"shares":2303,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":2303},"source":{"system":"sec-edgar","filing":"0001209191-18-056073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919118056073/doc4.xml","form_type":"4"}},{"id":3784207,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-10-24T17:01:47.000Z","date":"2018-10-22","kind":"sale","acquired":false,"shares":3,"price":5,"value":15.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."}],"balance_after":2303,"derivative":{"underlying":"Common Stock","underlying_shares":3},"source":{"system":"sec-edgar","filing":"0001209191-18-056073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919118056073/doc4.xml","form_type":"4"}},{"id":3784206,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Series B Preferred Stock","published_at":"2018-10-24T17:01:47.000Z","date":"2018-10-22","kind":"other","acquired":true,"shares":103,"price":0.12,"value":12.36,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."}],"balance_after":2306,"derivative":{"underlying":"Common Stock","underlying_shares":103},"source":{"system":"sec-edgar","filing":"0001209191-18-056073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919118056073/doc4.xml","form_type":"4"}},{"id":3784205,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Warrants to Purchase Series B Preferred Stock","published_at":"2018-10-24T17:01:47.000Z","date":"2018-10-22","kind":"other","acquired":false,"shares":103,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F2","text":"Represents the net exercise of the warrants immediately prior to, and contingent upon, the closing of the Issuer's initial public offering."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The warrants were exercisable until, and were scheduled to expire upon, the closing of the Issuer's initial public offering."}],"balance_after":0,"derivative":{"exercise_price":0.12,"underlying":"Series B Preferred Stock","underlying_shares":103},"source":{"system":"sec-edgar","filing":"0001209191-18-056073","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919118056073/doc4.xml","form_type":"4"}},{"id":3784204,"issuer":{"id":113305,"kind":"organization","name":"PhaseBio Pharmaceuticals Inc","symbol":"PHAS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-24T17:01:47.000Z","date":"2018-10-22","kind":"exercise","acquired":true,"shares":2303,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each share of Preferred Stock converted into Common Stock on a one-for-one basis upon the closing of the Issuer's initial public offering and has no expiration date."}],"balance_after":2303,"source":{"system":"sec-edgar","filing":"0001209191-18-056073","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1169245/000120919118056073/doc4.xml","form_type":"4"}},{"id":3797813,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-03T16:43:48.000Z","date":"2018-10-01","kind":"grant","acquired":true,"shares":2670,"price":4.54,"value":12121.8,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This common stock was issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly\nretainer fees. The number of shares of common stock is equal to $12,125  divided by $4.54, the closing price of Issuer's common stock on the\nNYSE American on October 1, 2018."}],"balance_after":17917,"source":{"system":"sec-edgar","filing":"0001209191-18-053853","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919118053853/doc4.xml","form_type":"4"}},{"id":3872263,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-07-05T16:49:18.000Z","date":"2018-07-02","kind":"grant","acquired":true,"shares":2737,"price":4.43,"value":12124.91,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This common stock was issued to the Reporting Person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly\nretainer fees. The number of shares of common stock is equal to $12,125  divided by $4.43, the closing price of Issuer's common stock on the\nNYSE American on July 2, 2018."}],"balance_after":15247,"source":{"system":"sec-edgar","filing":"0001209191-18-041699","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919118041699/doc4.xml","form_type":"4"}},{"id":3910214,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-01T16:30:25.000Z","date":"2018-05-30","kind":"grant","acquired":true,"shares":50847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the NYSE American on the date of grant, May 30, 2018."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made as compensation for the reporting person's service on the Issuer's board of directors. Under the Issuer's non-employee\ndirector compensation policy, each non-employee director who continues to serve as a member of the Issuer's board of directors is eligible to\nreceive an annual stock option grant following each annual meeting of the Issuer's stockholders. The number of shares underlying the option is\nequal to a Black Scholes option value of $106,500."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the option will vest in full on the earlier of the one year anniversary of the date of grant or the next annual stockholders\nmeeting, subject to the reporting person's continuous service (as defined in the Issuer's 2015 Equity Incentive Plan, as amended) through such\nvesting date."}],"balance_after":50847,"derivative":{"exercise_price":3.27,"expiration_date":"2028-05-29","underlying":"Common Stock","underlying_shares":50847},"source":{"system":"sec-edgar","filing":"0001209191-18-034691","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919118034691/doc4.xml","form_type":"4"}},{"id":3966793,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-04-09T16:53:07.000Z","date":"2018-04-02","kind":"grant","acquired":true,"shares":3911,"price":3.1,"value":12124.1,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly\nretainer fees. The number of shares of common stock is equal to $12,125  divided by $3.10, the closing price of issuer's common stock on the\nNYSE American on April 2, 2018, the last trading day of the prior quarter."}],"balance_after":12510,"source":{"system":"sec-edgar","filing":"0001209191-18-024359","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919118024359/doc4.xml","form_type":"4"}},{"id":4106602,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-01-04T20:00:50.000Z","date":"2018-01-02","kind":"grant","acquired":true,"shares":4558,"price":2.66,"value":12124.28,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"This common stock was issued to the reporting person pursuant to the Issuer's non-employee director compensation policy in lieu of quarterly\nretainer fees. The number of shares of common stock is equal to $12,125 divided by $2.66, the closing price of issuer's common stock on the\nNYSE American on December 29, 2017, the last trading day of the prior quarter."}],"balance_after":8599,"source":{"system":"sec-edgar","filing":"0001209191-18-002264","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919118002264/doc4.xml","form_type":"4"}},{"id":4185554,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-10-16T20:11:41.000Z","date":"2017-10-12","kind":"grant","acquired":true,"shares":4041,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":4041,"source":{"system":"sec-edgar","filing":"0001209191-17-057046","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919117057046/doc4.xml","form_type":"4"}},{"id":4302435,"issuer":{"id":5469,"kind":"organization","name":"Senseonics Holdings, Inc.","symbol":"SENS"},"owners":[{"id":67060,"kind":"person","name":"Klein Peter Justin","position":1,"cik":"0001608710","reported_name":"Klein Peter Justin","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-05-26T17:25:32.000Z","date":"2017-05-24","kind":"grant","acquired":true,"shares":128817,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"The exercise price is equal to the closing price of the Issuer's common stock on the NYSE-MKT on the date of grant, May 24, 2017."},{"field":"shares","element":"transactionShares","label":"F2","text":"This grant was made as compensation for the reporting person's service on the Issuer's board of directors. Under the Issuer's non-employee\ndirector compensation policy, each non-employee director who continues to serve as a member of the Issuer's board of directors is eligible to\nreceive an annual stock option grant following each annual meeting of the Issuer's stockholders. The number of shares underlying the option is\nequal to a Black Scholes option value of $106,500."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying the option will vest in full on the one year anniversary of the date of grant, subject to the reporting person's continuous\nservice through the vesting date."}],"balance_after":128817,"derivative":{"exercise_price":1.35,"expiration_date":"2027-05-23","underlying":"Common Stock","underlying_shares":128817},"source":{"system":"sec-edgar","filing":"0001209191-17-035954","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1608710/000120919117035954/doc4.xml","form_type":"4"}}]}